His interview comes after a weekend in which the vaccine cleared its final hurdle for US emergency use — being approved for people 16 and older — and as hundreds of thousands of vials are loaded on trucks for delivery to all 50 states.
Dr. Robert Redfield, director of the US Centers for Disease Control and Prevention, and Dr. Stephen Hahn, commissioner of the US Food and Drug Administration, have expressed hope that the immunizations begin Monday, as soon as the vials land in health care workers’ hands. Several state officials have indicated vaccinations will begin Monday.

Bourla’s remarks also come as the US is expected to soon see its coronavirus death toll hit 300,000.

No deal for US second quarter yet

The 50 million doses scheduled for distribution this year have already been manufactured, the CEO said, and half will go to the United States, while the other 25

Read More

NINE VACCINES against covid-19 have already been approved in one jurisdiction or another, with many more in various stages of preparation. That this has happened within a year of the illness coming to the world’s attention is remarkable. But it is one thing to design and test vaccines. It is another to make them at sufficient scale to generate the billions of doses needed to vaccinate the world’s population, and to do so at such speed that the rate of inoculation can outpace the spread and possible mutation of the virus.

Listen to this story

Enjoy more audio and podcasts on iOS or Android.

Broadly, there are two ways of making antiviral vaccines. One, tried and trusted, involves growing, in tanks called bioreactors, cell cultures that act as hosts for viruses which are then used in one way

Read More

He also announced he would direct states to prioritize teachers in their vaccination plans, reemphasizing a commitment to returning students to classrooms amid a confusing administration stance on when and how classrooms can reopen.

The new date does not mean all Americans would receive shots by May 31; issues with distribution and personnel mean it could take much longer for all doses to be administered.

But the speedier estimate, helped along by a new partnership between major US drugmakers, makes for an optimistic target as millions of Americans wait to receive their first doses. The timeline speeds up by two months the administration’s previous goal of having enough shots by the end of July.

“That’s progress,” Biden said in remarks from the White House, warning there could still be delays in getting shots in Americans’ arms and suggesting the country would not return to full normalcy for much longer.

“There

Read More

Pharmaceutical giant Merck will help manufacture Johnson & Johnson’s COVID-19 vaccine.

Alex Gottschalk/DeFodi Images via Getty Images


hide caption

toggle caption

Alex Gottschalk/DeFodi Images via Getty Images

Pharmaceutical giant Merck will help manufacture Johnson & Johnson’s COVID-19 vaccine.

Alex Gottschalk/DeFodi Images via Getty Images

Pharmaceutical giant Merck will help manufacture Johnson & Johnson’s COVID-19 vaccine, White House press secretary Jen Psaki announced Tuesday, calling it “an unprecedented historic step,” considering that the two companies are normally competitors.

Merck will produce the drug substance at the heart of Johnson & Johnson’s vaccine as well as work on filling vaccine vials and getting them ready for distribution.

“The U.S. government will facilitate this partnership in several key ways, including invoking the Defense Production Act to equip two Merck facilities to the standards necessary to safety manufacture the vaccine and asking the Department of Defense to provide daily logistical support to strengthen Johnson

Read More


Two workers in an underground mine.

  • Dr. Thuthula Balfour, head of health at Minerals Council South Africa said the cost of the vaccine programme to the mining industry could be around R300 million.
  • Mining is a key driver of the country’s economy, contributing 9% of GDP
  • SA has a labour-intensive mining industry with thousands of miners working in confined spaces deep underground, posing a higher risk of transmission

SA’s mining industry estimates it will cost around R300 million to help the government roll out Covid-19 vaccines to mineworkers and community members as the country battles a surge in infections, the industry body has told Reuters. 

The Minerals Council, which represents mining firms, offered its financial and logistical assistance after the government called on the private sector to help with the rollout of vaccines, the first of which are set to arrive on Monday.

Mining is a key driver

Read More

KUALA LUMPUR: Phamaniaga Bhd has the capacity to manufacture two million doses of COVID-19 vaccine developed by Sinovac Life Sciences Co Ltd per month beginning March this year.

Group managing director Datuk Zulkarnain Md Eusope said the vaccine would be the first to be manufactured in Malaysia at the small volume injectable high-tech plant owned by Pharmaniaga‘s wholly-owned subsidiary, Pharmaniaga LifeSciences Sdn Bhd, in Puchong.

He said the group would invest RM3 million to retrofit the plant to enable the production of the vaccine.

“We are very confident in carrying out the task successfully because our technical experts have been working on setting up a halal vaccine plant in Malaysia since 2017.

“When the COVID-19 spread around the world early last year, we immediately chanelled our team to work with our global partners, including Sinovac on the fill and finish manufacturing activity and technology transfer to speed up the

Read More